Atropine Auto-Injector
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2DP-27-R-ATRO
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a Sources Sought notice for the procurement of Atropine Auto-Injectors. This market research initiative, identified by procurement number SPE2DP-27-R-ATRO, seeks to gather information from potential suppliers capable of manufacturing pharmaceutical preparations, specifically Atropine Auto-Injectors, in accordance with NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505.
The primary objective of this notice is to identify qualified sources within the pharmaceutical manufacturing sector that can reliably supply Atropine Auto-Injectors. These devices are critical for medical and defense applications, particularly in emergency situations requiring rapid administration of atropine. The intended outcome is to inform future procurement strategies and ensure the availability of this essential medical product for DLA Troop Support operations.
The scope of the notice encompasses the manufacturing and delivery of Atropine Auto-Injectors to the place of performance, which is specified as Philadelphia, Pennsylvania, United States. The notice does not indicate any set-aside requirements, meaning it is open to all qualified vendors regardless of business size or socioeconomic status.
Key requirements include compliance with pharmaceutical manufacturing standards as outlined in NAICS 325412, and the ability to deliver products that meet the specifications and quality expectations of the Defense Logistics Agency. While the notice does not provide detailed technical requirements or expected deliverables, interested parties are encouraged to review the attached market research survey and MPID for further information.
The contracting entity is DLA Troop Support, a federal office within the Defense Logistics Agency. Primary and secondary points of contact for this opportunity are Alec Deichman ([email protected], 445-737-5743) and Jessica De La Hoz ([email protected], 445-737-3623), respectively. The notice is currently active, with a response deadline set for December 1, 2026.
Contractors evaluating this opportunity should consider their capabilities in pharmaceutical preparation manufacturing, particularly in producing auto-injector devices for medical use. The absence of set-aside restrictions and the focus on market research suggest that DLA Troop Support is seeking broad industry input to inform future acquisition strategies. Interested parties should review the notice and any associated documents via the provided SAM.gov link for additional context and instructions on how to participate.
For further details and to access the official notice, visit: https://sam.gov/opp/6dd39a2f02074d0fbdcfe109adb2a702/view